Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension
NCT00984932
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Systemic Sclerosis
Interventions
DRUG:
Rosuvastatin
Sponsor
University of Alexandria